VBI Vaccines (NASDAQ:VBIV) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of VBI Vaccines (NASDAQ:VBIV – Free Report) in a research note issued to investors on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock. VBI Vaccines Stock Up 0.2 % Shares of VBI Vaccines stock opened at $0.62 on Friday. The business has a 50 day moving […]

Leave a Reply

Your email address will not be published.

Previous post TPG (NASDAQ:TPG) Now Covered by TD Cowen
Next post Xcel Energy (NASDAQ:XEL) Price Target Raised to $68.00 at KeyCorp